Work for PhaseRx, Inc.?

Claim Your Profile

PhaseRx, Inc. Logo Image

PhaseRx, Inc.

PhaseRx, Inc. Banner Image

Most Recent Annual Report

Upgrade your company profile to unlock all of your annual report content on AnnualReports.co.uk

2016 Annual Report, Interactive Annual Report and Form 10K

PhaseRx, Inc.

PhaseRx, Inc. has reached its limit for free report views.

PhaseRx, Inc. does not currently have any hardcopy reports on AnnualReports.co.uk. Click the button below to request a report when hardcopies become available.

About PhaseRx, Inc.

11-50 Employees
Based in Seattle, Washington

PhaseRx is a biopharmaceutical company dedicated to developing mRNA products for the treatment of children with inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy (i-ERT). PhaseRx's initial product development focus is on urea cycle disorders, a group of rare genetic diseases that generally present before the age of twelve and are characterized by the body's inability to remove ammonia from the blood with potentially devastating consequences for patients.

Ticker:
PZRX
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol